TOP2A, DNA topoisomerase II alpha, 7153

N. diseases: 200; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.060 Biomarker disease BEFREE Further analysis revealed that TOP2A had prognostic significance in early-stage lung cancer patients, and its expression correlated with levels of immune cell infiltration, especially dendritic cells (DCs). 31816603 2019
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.060 Biomarker disease BEFREE Anti-TOP2A and anti-ACTR3 have the potential to serve as a serological biomarkers in early stage LC. 31839396 2019
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.060 GeneticVariation disease BEFREE Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese. 28231233 2017
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.060 Biomarker disease BEFREE These podophyllotoxin analogs inhibited DNA topoisomerase IIα and induced mitochondrial mediated apoptosis in lung cancer cell line, A549. 26386574 2015
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.060 AlteredExpression disease BEFREE The data presented herein suggest that the expression of HER2 did not influence the SM-induced apoptosis of different types of lung cancer cells and that the SM up-regulation of HER2 and TOP2A expressions simultaneously augmented trastuzumab and epirubicin-induced deaths of lung cancer H661 and H69 cells. 18078328 2008
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.060 GeneticVariation disease BEFREE A truncated cytoplasmic topoisomerase IIalpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34. 10699927 2000